genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
News
Artificial Proteins Give Living Cells a Computational Upgrade
Artificial Intelligence
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
News
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Coronavirus
Possible SARS-CoV-2 Vulnerability Revealed by Human Antibody
Coronavirus
Anti-Parasitic Drug Halts Coronavirus Replication in Lab-Grown Cells within 48 Hours
Insights
All
Trends for 2020
Commentary
Understanding Glycans in COVID-19 Drug Design
Coronavirus
NYC Scientists Swab the Subway in Search of SARS-CoV-2
Artificial Intelligence
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Artificial Proteins Give Living Cells a Computational Upgrade
Artificial Intelligence
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
News
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Coronavirus
Anti-Parasitic Drug Halts Coronavirus Replication in Lab-Grown Cells within 48 Hours
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
April 2020 Vol. 40 No.4
Protein Labeling Kit
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Leukemia
Leukemia
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Leukemia
Trivalent CAR T Cells a Triple Threat to Leukemia Cells
Leukemia
Using Nanopore Sequencing to Study Full-Length Transcripts and Splicing Isoforms
Leukemia
Mutations Causing Drug Resistance Modeled by Engineers
Leukemia
Gilead to Acquire Forty Seven for $4.9B, Expanding Immuno-Oncology Pipeline
Leukemia
CLL Drug Study Finds Single-Cell Analysis Can Gauge Patients’ Response Rates
Leukemia
Leukemia’s Favorite Fix, Vitamin B6, Vulnerable to Pharmacological Blockade
Leukemia
Leukemia Reliable Diagnosed by AI in New Study
Leukemia
Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Leukemia
Amgen Expands China Presence, Cancer R&D with $2.7B BeiGene Collaboration
Leukemia
3D Living-Cell Model Offers Insights into Bone Disease and Regeneration
Leukemia
Chimerix Licenses Cantex’s CX-01 for AML after Promising Phase II Results
Leukemia
ImmunoGen Axing Nearly 75% of Workforce, Shrinking Pipeline and Facilities
Leukemia
Celyad Faces “Go-or-No-Go” Decisions on Lead CAR-T Candidates
Leukemia
Leukemia Protein Atlas Holds Power to Accelerate Precision Medicine
Leukemia
Potent Cancer Drug Combos Identified with New Screening Tool
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
